About
DT-Axis develops a smartphone app-based digital therapeutics program to support depression treatment, with its flagship product Lifton D® approved in Japan as an adjunctive treatment for depression.
Explore DT-Axis Co., Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.